Insilico Medicine Integrates Nach01 Foundation Model with Microsoft Discovery for AI-Native Drug Discovery

Insilico Medicine has integrated its Nach01 foundation model with Microsoft Discovery to enable AI-native, enterprise-ready drug discovery workflows in a secure Azure environment.1

Nach01 supports end-to-end pipelines including molecule generation, ADMET property prediction, lead optimization, and integration with tools like QSAR models.1

The integration enhances transparency, reproducibility, and scalability for R&D teams, addressing challenges in disconnected computational environments.1

Insilico plans to publish Nach01 on the Microsoft Marketplace for easy registration and workflow orchestration.1

Microsoft highlights how this collaboration empowers organizations with agentic AI to accelerate therapy development.1

Sources:

1. https://insilico.com/news/insilico-medicine-integrates-nach01-foundation-model-with-microsoft-discovery